NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions

NCT01783600 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

NETWORK

Sponsor class

Conditions

Peripheral Arterial Disease

Interventions

DEVICE: NanoCross .014 balloon catheter

Sponsor

Flanders Medical Research Program